EcoDrugPlus

Aryl Hydrocarbon Receptor

Ensembl ID : ENSDNOG00000003198
Gene Symbol: AHR
2 Cross references
155 Possible Orthologues:

Aurora Kinase A

Ensembl ID : ENSDNOG00000041342
Gene Symbol: AURKA
4 Cross references
236 Possible Orthologues:

Aurora Kinase B

Ensembl ID : ENSDNOG00000007434
Gene Symbol: AURKB
4 Cross references
205 Possible Orthologues:

Aurora Kinase C

Ensembl ID : ENSDNOG00000015683
Gene Symbol: AURKC
2 Cross references
99 Possible Orthologues:

Beta-Secretase 1

Ensembl ID : ENSDNOG00000015297
Gene Symbol: BACE1
2 Cross references
220 Possible Orthologues:

Bradykinin Receptor B2

Ensembl ID : ENSDNOG00000049611
Gene Symbol: BDKRB2
4 Cross references
362 Possible Orthologues:

Butyrylcholinesterase

Ensembl ID : ENSDNOG00000041422
Gene Symbol: BCHE
4 Cross references
130 Possible Orthologues:

Calcitonin Receptor Like Receptor

Ensembl ID : ENSDNOG00000036313
Gene Symbol: CALCRL
4 Cross references
149 Possible Orthologues:

Calcium Sensing Receptor

Ensembl ID : ENSDNOG00000015243
Gene Symbol: CASR
4 Cross references
203 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 1

Ensembl ID : ENSDNOG00000017761
Gene Symbol: CACNA2D1
2 Cross references
288 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 2

Ensembl ID : ENSDNOG00000044754
Gene Symbol: CACNA2D2
2 Cross references
269 Possible Orthologues:

Calcium Voltage-Gated Channel Auxiliary Subunit Alpha2delta 4

Ensembl ID : ENSDNOG00000018409
Gene Symbol: CACNA2D4
2 Cross references
316 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).